Webinar
Biosimilars - A Mid-Year Review 2017
This webinar has ended.
Hosts
-
- Name
- Person title
- Principal
To access a recording of this webinar or receive a copy of the slides, please contact [email protected].
On Wednesday, August 16, we hosted a mid-year review of recent biosimilars litigation, including the Supreme Court’s opinion in Amgen v. Sandoz. Fish attorneys Betsy Flanagan and Michael Amon, discussed the following topics:
- Recent district court and Federal Circuit litigation
- Implications of the opinion in Amgen v. Sandoz
- Recent Patent Trial and Appeal Board cases of note; and the impact of these cases and decisions on the biologics and biosimilars markets.